Cosmo Bio Company,Limited (3386.T)
- Previous Close
988.00 - Open
988.00 - Bid 990.00 x --
- Ask 996.00 x --
- Day's Range
985.00 - 997.00 - 52 Week Range
937.00 - 1,072.00 - Volume
1,300 - Avg. Volume
6,034 - Market Cap (intraday)
5.789B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
13.06 - EPS (TTM)
75.98 - Earnings Date May 9, 2024
- Forward Dividend & Yield 30.00 (3.04%)
- Ex-Dividend Date Jun 27, 2024
- 1y Target Est
--
Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as offers detection reagents, cell and tissue culture systems, gene analysis systems, and others. It also provides research instruments comprising electrophoresis apparatuses, cell culture labware, gene manipulation systems, data analysis software, and others; drug discovery and custom research services; and clinical diagnostics. In addition, the company develops and manufactures cell/cell culture products, including adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem, and feeder cells, as well as tumor cell lines, coating reagents, macrophage-related products, etc.; and assay kit related products that comprise various measurement kits, staining kits, detection/purification kits, etc. Further, it offers biotechnology research equipment, which include constant-temperature transport containers, aluminum block mat heat insulation devices, dew condensation prevention glass plates, etc.; and consigned, custom peptide synthesis, and antibody production services. The company serves laboratories, research institutes, and life-science education and testing organizations. It sells its products through outlets in Japan, as well as a network of sales agents internationally. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Tokyo, Japan.
www.cosmobio.co.jp155
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 3386.T
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3386.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3386.T
Valuation Measures
Market Cap
5.77B
Enterprise Value
2.76B
Trailing P/E
13.01
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.62
Price/Book (mrq)
0.68
Enterprise Value/Revenue
0.30
Enterprise Value/EBITDA
3.45
Financial Highlights
Profitability and Income Statement
Profit Margin
4.73%
Return on Assets (ttm)
3.07%
Return on Equity (ttm)
5.23%
Revenue (ttm)
9.34B
Net Income Avi to Common (ttm)
442M
Diluted EPS (ttm)
75.98
Balance Sheet and Cash Flow
Total Cash (mrq)
3.02B
Total Debt/Equity (mrq)
0.22%
Levered Free Cash Flow (ttm)
481.62M
Company Insights: 3386.T
3386.T does not have Company Insights